Author(s)

Anh Quang Luong^1,2, Thang Ngoc Vu³, Dang Hoa Nguyen⁴, Sultan M. Alshahrani⁵, John Mark Christensen^5*, Chien Ngoc Nguyen^6*

¹Department of Pharmacy, National Institute of Burns, Hanoi, Vietnam.
²Research and Training Center for Pharmacy, Military Medical University, Hanoi, Vietnam.
³Military Institute of Pharmaceutical Analysis and Research, Hanoi, Vietnam.
⁴Department of Pharmaceutics, Hanoi University of Pharmacy, Hanoi, Vietnam.
⁵Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, Oregon, USA.
⁶National Institute of Pharmaceutical Technology, Hanoi University of Pharmacy, Hanoi, Vietnam.

An optimized formulation of capsules containing Lansoprazole enteric-coated pellets using D-Optimal design with a polynomial statistical model were prepared by using Eudragit?L100 as an enteric coated polymer to provide resistance to simulated gastric acid dissolution in buffer media. D-Optimal experimental design was used to determine the optimal level for three coating layers that were applied to formulate the enteric-coated pellets including a drug loading layer, a sub-coating, and an outer enteric coating. Dissolution studies were performed on the prepared Lansoprazole capsules. Less than 5 percent of Lansoprazole was released in 60 minutes in an acidic dissolution medium (pH 1.2) and greater than 90 percent of active ingredient was released in the next 60 minutes in a buffer dissolution medium (pH 6.8). The Lansoprazole capsules were stable with no observable change in physico-chemical properties in accelerated and normal storage conditions for 6 and 18 months, respectively. The pharmacokinetic parameters C_max, T_max, AUC_0-t, and AUC_0-∞ were determined after administration of the D-Optimal design optimized capsules of LPZ to healthy beagle dogs and were statistically compared to Gastevin? capsules as a reference (KRKA, Slovenia) using the non-compartmental method with the aid of WinNonlin 5.2 software. The analysis of variance showed that the two formulations did not demonstrate bioequivalence using a 90% confidence interval range (80% - 120%) of C_max, AUC_0-t, and AUC_0-∞. No significant difference in T_max was found at the 0.95 significance level using the Wilcoxon signed-rank test. D-Optimal Experimental Design provided definitive direction for an optimal formulation of capsules containing enteric-coated pellets of lansoprazole loaded within the coating of pellets that provided similar bioequivalence to Gastevin.

Lansoprazole, D-Optimal, Pellets, Enteric-Coating, Pharmacokinetic Parameters

Quang Luong, A. , Ngoc Vu, T. , Hoa Nguyen, D. , M. Alshahrani, S. , Mark Christensen, J. and Ngoc Nguyen, C. (2017) Formulation Optimization Utilizing D-Optimal Experimental Design of Oral Capsules Containing Enteric-Coated Pellets of Lansoprazole and in vivo Bioequivalence. Pharmacology & Pharmacy, 8, 153-171. doi: 10.4236/pp.2017.85011.